Muscle reinnervation and IGF-I synthesis are affected by exposure to heparin: an effect partially antagonized by anti-growth hormone-releasing hormone
- PMID: 12587674
- DOI: 10.1023/a:1021616716463
Muscle reinnervation and IGF-I synthesis are affected by exposure to heparin: an effect partially antagonized by anti-growth hormone-releasing hormone
Abstract
Sciatic nerve crush was performed in 2-day-old rats, then reinnervation of the extensor digitorum longus muscle, motor neuron survival, and muscle IGF-I production were monitored. In saline-treated rats, the extent of reinnervation was around 50% and the number of EDL reinnervating motor neurons was significantly reduced. In heparin-treated rats the extent of muscle reinnervation, the recovery of nerve-evoked muscle twitch tension, and the number of motor neurons reinnervating the extensor digitorum longus muscle were greatly enhanced compared to saline-treated rats. In addition, treatment with heparin increased markedly insulin-like growth factor-I levels in denervated muscles. The concomitant exposure to anti-growth hormone releasing hormone partially abolished the stimulatory action of heparin on muscle reinnervation and prevented the increase of insulin-like growth factor-I muscle levels.
Similar articles
-
Glycosaminoglycan-promoted muscle reinnervation and insulin-like growth factor-I levels are affected by anti-growth hormone-releasing hormone exposure.J Neurosci Res. 2001 Dec 15;66(6):1112-7. doi: 10.1002/jnr.10025. J Neurosci Res. 2001. PMID: 11746443
-
Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotes muscle reinnervation.J Neurosci Res. 1998 Dec 15;54(6):840-7. doi: 10.1002/(SICI)1097-4547(19981215)54:6<840::AID-JNR12>3.0.CO;2-L. J Neurosci Res. 1998. PMID: 9856868
-
Glycosaminoglycans treatment increases IGF-I muscle levels and counteracts motor neuron death: A novel nonanticoagulant action.J Neurosci Res. 1999 Feb 15;55(4):496-505. doi: 10.1002/(SICI)1097-4547(19990215)55:4<496::AID-JNR9>3.0.CO;2-6. J Neurosci Res. 1999. PMID: 10723059
-
Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review.Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):339-46. doi: 10.1016/s0736-5748(00)00015-0. Int J Dev Neurosci. 2000. PMID: 10817918 Review.
-
Neuroprotection, neuroregeneration, and interaction with insulin-like growth factor-I: novel non-anticoagulant action of glycosaminoglycans.J Neurosci Res. 1998 Mar 1;51(5):559-62. doi: 10.1002/(SICI)1097-4547(19980301)51:5<559::AID-JNR2>3.0.CO;2-E. J Neurosci Res. 1998. PMID: 9511999 Review.
Cited by
-
Insulin-Like Growth Factor-1: A Promising Therapeutic Target for Peripheral Nerve Injury.Front Bioeng Biotechnol. 2021 Jun 24;9:695850. doi: 10.3389/fbioe.2021.695850. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34249891 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases